Cargando…

The mechanisms of immune response and evasion by the main SARS-CoV-2 variants

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic. SARS-CoV-2 carries a unique group of mutations, and the transmission of the virus has led to the emergence of other mutants such as Alpha (B.1.1.7), Beta (B.1.351)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Qiuli, Zhang, Jiawei, Wang, Peter, Zhang, Zuyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436868/ https://www.ncbi.nlm.nih.gov/pubmed/36068846 http://dx.doi.org/10.1016/j.isci.2022.105044

Ejemplares similares

Mechanisms of Antiviral Immune Evasion of SARS-CoV-2
por: Beyer, Daniel K., et al.
Publicado: (2022)

Structural Plasticity and Immune Evasion of SARS-CoV-2 Spike Variants
por: Ghimire, Dibya, et al.
Publicado: (2022)

Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants
por: Sun, Cong, et al.
Publicado: (2022)

Evaluation of immune evasion in SARS-CoV-2 Delta and Omicron variants
por: Chaudhari, Armi M., et al.
Publicado: (2022)

Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
por: Cai, Yongfei, et al.
Publicado: (2021)

The immune response and immune evasion characteristics in SARS-CoV, MERS-CoV, and SARS-CoV-2: Vaccine design strategies
por: Molaei, Soheila, et al.
Publicado: (2021)

SARS-CoV-2 Delta variant excels at membrane fusion, but not immune evasion
por: Flemming, Alexandra
Publicado: (2021)

The viral phoenix: enhanced infectivity and immunity evasion of SARS-CoV-2 variants
por: Choi, Hosoon, et al.
Publicado: (2021)

Immune Evasive Effects of SARS-CoV-2 Variants to COVID-19 Emergency Used Vaccines
por: Zhang, Yandi, et al.
Publicado: (2021)

SARS-CoV-2: A Master of Immune Evasion
por: Rubio-Casillas, Alberto, et al.
Publicado: (2022)

Immune Evasion of SARS-CoV-2 Omicron Subvariants
por: Ke, Hanzhong, et al.
Publicado: (2022)

Innate immune evasion strategies of SARS-CoV-2
por: Minkoff, Judith M., et al.
Publicado: (2023)

Structural Evaluation of the Spike Glycoprotein Variants on SARS-CoV-2 Transmission and Immune Evasion
por: Salleh, Mohd Zulkifli, et al.
Publicado: (2021)

Insights into the limited global spread of the immune evasive SARS-CoV-2 variant Mu
por: Petrone, Mary E., et al.
Publicado: (2022)

Evasion of vaccine-induced humoral immunity by emerging sub-variants of SARS-CoV-2
por: Koyama, Takahiko, et al.
Publicado: (2022)

SARS-CoV-2 Mutations Responsible for Immune Evasion Leading to Breakthrough Infection
por: Sahni, Chetan, et al.
Publicado: (2022)

Evasion of Neutralizing Antibody Response by the SARS-CoV-2 BA.2.75 Variant
por: Qu, Panke, et al.
Publicado: (2022)

Evasion of neutralizing antibody responses by the SARS-CoV-2 BA.2.75 variant
por: Qu, Panke, et al.
Publicado: (2022)

Innate Immunity Evasion Strategies of Highly Pathogenic Coronaviruses: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Li, Jin-Yan, et al.
Publicado: (2021)

SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion
por: Mlcochova, Petra, et al.
Publicado: (2021)

Glimpses into evolutionary trajectories of SARS-CoV-2: emerging variants and potential immune evasion routes
por: Anastassopoulou, Cleo, et al.
Publicado: (2021)

Evolution of enhanced innate immune evasion by SARS-CoV-2
por: Thorne, Lucy G., et al.
Publicado: (2021)

The role of SARS-CoV-2 accessory proteins in immune evasion
por: Zandi, Milad, et al.
Publicado: (2022)

Immune evasion of neutralizing antibodies by SARS-CoV-2 Omicron
por: Wang, Lidong, et al.
Publicado: (2023)

Translational shutdown and evasion of the innate immune response by SARS-CoV-2 NSP14 protein
por: Hsu, Jack Chun-Chieh, et al.
Publicado: (2021)

SARS-COV-2 Variants: Differences and Potential of Immune Evasion
por: Hirabara, Sandro M., et al.
Publicado: (2022)

Correction: SARS-CoV-2 Mutations Responsible for Immune Evasion Leading to Breakthrough Infection
por: Sahni, Chetan, et al.
Publicado: (2023)

Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?
por: Lazarevic, Ivana, et al.
Publicado: (2021)

SARS‐CoV‐2 variants preferentially emerge at intrinsically disordered protein sites helping immune evasion
por: Quaglia, Federica, et al.
Publicado: (2022)

SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern
por: McCallum, Matthew, et al.
Publicado: (2021)

Immune Evasion, Infectivity, and Fusogenicity of SARS-CoV-2 Omicron BA.2.86 and FLip Variants
por: Qu, Panke, et al.
Publicado: (2023)

SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies
por: Cox, MacGregor, et al.
Publicado: (2022)

Evolution of Immune Evasion and Host Range Expansion by the SARS-CoV-2 B.1.1.529 (Omicron) Variant
por: Ren, Wenlin, et al.
Publicado: (2023)

The effect of environmental pollution on immune evasion checkpoints of SARS-CoV-2
por: Engin, Ayse Basak, et al.
Publicado: (2021)

Immune evasion via SARS-CoV-2 ORF8 protein?
por: Park, Matthew D.
Publicado: (2020)

Immune evasion of SARS-CoV-2 from interferon antiviral system
por: Min, Yuan-Qin, et al.
Publicado: (2021)

Roles and functions of SARS-CoV-2 proteins in host immune evasion
por: Rashid, Farooq, et al.
Publicado: (2022)

Molecular mechanisms involved in pathogenicity of SARS-CoV-2: Immune evasion and implications for therapeutic strategies
por: Latifi-Pupovci, Hatixhe
Publicado: (2022)

Evasion of Type I Interferon by SARS-CoV-2
por: Xia, Hongjie, et al.
Publicado: (2020)

The battle between host and SARS-CoV-2: Innate immunity and viral evasion strategies
por: Zhang, Shilei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l8csrgla0j5p6ruje4491b69c8